Institutional Ownership Neurocrine Biosciences Inc (NBIX)
This table provides information about the institutional ownership of Neurocrine Biosciences Inc (NBIX). We have compiled data on the 654 institutions that hold shares in the stock, with a total of 96.5 Million shares, which have been reported (via 13F filing form) to have a value of $11.5 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
First Trust Advisors LP
Wheaton, IL |
Feb 13, 2025 Q4 2024 |
394,652
shares
|
$47 Million
0.05% of portfolio
|
Q4 2024
Reduced 27.5%
|
|
Primecap Management CO
Pasadena, CA |
Feb 10, 2025 Q4 2024 |
393,710
shares
|
$46.9 Million
0.04% of portfolio
|
Q4 2024
Reduced 2.55%
|
|
Hood River Capital Management LLC
Palm Beach Gardens, FL |
Feb 14, 2025 Q4 2024 |
355,058
shares
|
$42.3 Million
0.84% of portfolio
|
Q4 2024
Added 34.9%
|
|
Legal & General Group PLC
London, X0 |
Feb 13, 2025 Q4 2024 |
345,690
shares
|
$41.2 Million
0.01% of portfolio
|
Q4 2024
Reduced 34.68%
|
|
Ray Dalio
Bridgewater Associates, LP | Westport, Ct
|
Feb 13, 2025 Q4 2024 |
332,598
shares
|
$39.6 Million
0.22% of portfolio
|
Q4 2024
Added 146.03%
|
|
Norges Bank
Oslo, Q8 |
Feb 12, 2025 Q4 2024 |
325,295
shares
|
$38.7 Million
0.01% of portfolio
|
Q4 2024
New holding
|
|
Rhumbline Advisers
Boston, MA |
Jan 30, 2025 Q4 2024 |
320,478
shares
|
$38.2 Million
0.04% of portfolio
|
Q4 2024
Reduced 0.39%
|
|
Clearbridge Investments, LLC
New York, NY |
Feb 12, 2025 Q4 2024 |
319,299
shares
|
$38 Million
0.04% of portfolio
|
Q3 2024
Reduced 6.31%
|
|
Iron Triangle Partners LP
Cos Cob, CT |
Feb 14, 2025 Q4 2024 |
318,195
shares
|
$37.9 Million
4.89% of portfolio
|
Q4 2024
New holding
|
|
Sarissa Capital Management LP
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
309,116
shares
|
$36.8 Million
13.07% of portfolio
|
Q4 2024
Reduced 24.69%
|
|
Candriam S.C.A.
|
Feb 06, 2025 Q4 2024 |
303,972
shares
|
$36.2 Million
0.25% of portfolio
|
Q4 2024
Reduced 37.1%
|
|
Axa S.A.
Paris, I0 |
Feb 14, 2025 Q4 2024 |
297,704
shares
|
$35.5 Million
0.13% of portfolio
|
Q4 2024
Added 10.6%
|
|
Swiss National Bank
Zurich, V8 |
Feb 10, 2025 Q4 2024 |
285,300
shares
|
$34 Million
0.03% of portfolio
|
Q4 2024
Reduced 4.49%
|
|
Macquarie Group LTD
Australia, C3 |
Feb 14, 2025 Q4 2024 |
274,126
shares
|
$32.7 Million
0.04% of portfolio
|
Q4 2024
Reduced 44.3%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
267,980
shares
|
$31.9 Million
0.01% of portfolio
|
Q4 2024
Reduced 22.45%
|
|
Amundi
Paris, I0 |
Feb 07, 2025 Q4 2024 |
261,860
shares
|
$31.2 Million
0.01% of portfolio
|
Q4 2024
Reduced 60.12%
|
|
Impax Asset Management Group PLC
|
Feb 04, 2025 Q4 2024 |
261,599
shares
|
$31.2 Million
0.18% of portfolio
|
Q4 2024
Added 207.76%
|
|
Principal Financial Group Inc
Des Moines, IA |
Jan 31, 2025 Q4 2024 |
252,469
shares
|
$30.1 Million
0.02% of portfolio
|
Q4 2024
New holding
|
|
Alyeska Investment Group, L.P.
Chicago, IL |
Feb 14, 2025 Q4 2024 |
248,928
shares
|
$29.6 Million
0.14% of portfolio
|
Q4 2024
New holding
|
|
Wells Fargo & Company
San Francisco, CA |
Feb 12, 2025 Q4 2024 |
246,579
shares
|
$29.4 Million
0.01% of portfolio
|
Q4 2024
Reduced 5.31%
|
|
Sumitomo Mitsui Trust Holdings, Inc.
|
Jan 28, 2025 Q4 2024 |
232,857
shares
|
$27.7 Million
0.02% of portfolio
|
Q4 2024
Added 0.39%
|
|
Avidity Partners Management LP
Dallas, TX |
Feb 14, 2025 Q4 2024 |
220,400
shares
|
$26.3 Million
3.4% of portfolio
|
Q4 2024
Reduced 52.09%
|
|
Renaissance Group LLC
Covington, KY |
Feb 13, 2025 Q4 2024 |
217,572
shares
|
$25.9 Million
1.29% of portfolio
|
Q4 2024
Added 6.58%
|
|
Hsbc Holdings PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
212,354
shares
|
$25.3 Million
0.02% of portfolio
|
Q4 2024
Reduced 4.88%
|
|
Prudential Financial Inc
Newark, NJ |
Feb 11, 2025 Q4 2024 |
210,175
shares
|
$25 Million
0.04% of portfolio
|
Q4 2024
Added 18.93%
|